CYNTHIE KIEFER: Open Payments
NPI 1639327307 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,214 in 93 payments from 19 companies in 2025. Trend: 2023 $183 · 2024 $126 · 2025 $2,214
Food & beverage: $2,137Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $587 |
| Amgen Inc. | 11 | $230 |
| Janssen Biotech, Inc. | 7 | $192 |
| Mallinckrodt Hospital Products Inc. | 4 | $185 |
| UCB, Inc. | 7 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| ANI Pharmaceuticals, Inc. | 8 | $156 |
| GENZYME CORPORATION | 2 | $133 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| PFIZER INC. | 3 | $64 |
Products named: SKYRIZI, RINVOQ, TREMFYA, ACTHAR, Bimzelx, SAPHNELO, PURIFIED CORTROPHIN GEL, KEVZARA.
Industry payments across NV — which companies pay providers there.
